2022 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2022) - 9¿ù 3ÀÏ (3ÀÏÂ÷) : 2022-09-03±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : º¤½ºÄÚ
±³À°ÁÖÁ¦ :
(¿Â-¿ÀÇÁº´Çà) 2022 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2022) - 9¿ù 3ÀÏ (3ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ
´ã´çÀÚ : ¹ÚÁ¤Àº
¿¬¶ôó : 02-566-6031
À̸ÞÀÏ :
icbmt@icbmt.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í Àü¹®ÀÇ 150,000¿ø ÀüÀÓÀÇ, °£È£»ç, ¿¬±¸¿ø 80,000¿ø, Àü°øÀÇ 50,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 A 09:00~09:30 ''Risk stratification of GVHD(graft-versus-host disease) with clinical prediction system and novel biomarkers John E. Levine(The Tisch Cancer Institute USA)
±³À°½Ã°£ 09-03 A 09:30~10:00 Updated strategies of GVHD(graft-versus-host disease) prevention ÀÌÈ£¼·(°í½ÅÀÇ´ë)
±³À°½Ã°£ 09-03 A 10:00~10:30 Biology based novel treatment approaches of GVHD(graft-versus-host disease) Tomomi Toubai(Yamagata University Japan)
±³À°½Ã°£ 09-03 B 10:40~11:10 Single cell analysis reveals the human developmental hematopoiesis Anastasia N. Tikhonova(University of Toronto Canada)
±³À°½Ã°£ 09-03 B 11:10~11:40 Immunologic changes of BM niche in SAA or other immune-related hematologic disorders Satu Mustjoki(University of Helsinki Finland)
±³À°½Ã°£ 09-03 B 11:40~12:10 proteomic approach using EVs hematologic malignancies ±è±¤Ç¥(°æÈñ´ëÇб³)